Nobuta H, Stockley JH, Rowitch DH. New Recipes for Myelinating Oligodendrocytes. Cell Stem Cell. 2018;23(4):464-465. doi:10.1016/j.stem.2018.09.011
Tomassy GS, Dershowitz LB, Arlotta P. Diversity Matters: A Revised Guide to Myelination. Trends Cell Biol. 2016;26(2):135-147. doi:10.1016/j.tcb.2015.09.002
Giera S, Deng Y, Luo R, et al. The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development. Nat Commun. 2015;6:6121. doi:10.1038/ncomms7121
Miyake N, Wolf NI, Cayami FK, et al. X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1. Neurogenetics. 2017;18(4):185-194. doi:10.1007/s10048-017-0520-x
Petersen MA, Ryu JK, Chang KJ, et al. Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage. Neuron. 2017;96(5):1003-1012.e7. doi:10.1016/j.neuron.2017.10.008
van Tilborg E, de Theije CGM, van Hal M, et al. Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury. Glia. 2018;66(2):221-238. doi:10.1002/glia.23256
McPhie DL, Nehme R, Ravichandran C, et al. Oligodendrocyte differentiation of induced pluripotent stem cells derived from subjects with schizophrenias implicate abnormalities in development. Transl Psychiatry. 2018;8(1):230. doi:10.1038/s41398-018-0284-6
Fancy SPJ, Harrington EP, Yuen TJ, et al. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci. 2011;14(8):1009-16. doi:10.1038/nn.2855
Fancy SPJ, Chan JR, Baranzini SE, Franklin RJM, Rowitch DH. Myelin regeneration: a recapitulation of development?. Annu Rev Neurosci. 2011;34:21-43. doi:10.1146/annurev-neuro-061010-113629
Shafee R, Buckner RL, Fischl B. Gray matter myelination of 1555 human brains using partial volume corrected MRI images. Neuroimage. 2015;105:473-85. doi:10.1016/j.neuroimage.2014.10.054